Subcutaneous lisuride infusion in Parkinson’s disease: clinical results using different modes of administration
The continuous dopaminergic stimulation provided by infusion of dopamine agonist drugs, is a very effective strategy to control ON-OFF fluctuation in Parkinson’s disease. Lisuride is a potent dopamine agonist drug, very soluble in water and can be administred subcutaneously. Many authors have shown that the subcutaneous infusion of lisuride can control fluctuations when applied in combination with oral levodopa as a 24 hour continuous infusion regimen. In this study, lisuride was given without any other antiparkinsonian medicament and using a 12 hour infusion regimen wherever possible. 13 fluctuating Parkinsonian patients were studied. 6 out of these 13 were satisfactorly treated with lisuride alone and the remaining 7 with a combination of Lisuride + oral levodopa. Only in 3 out of 13 patients the 24 hour infusion regimen was required.
KeywordsInfusion Regimen Psychiatric Side Effect Dopa Decarboxylase Inhibitor Continuous Dopaminergic Stimulation Continuous Infusion Regimen
Unable to display preview. Download preview PDF.
- Bittkau S, Przuntek H (1986) Lisuride infusion pump for Parkinson’s disease. Lancet 2: 349Google Scholar
- Quinn N, Marion MH, Stocchi F, Jenner P, Marsden CD (1986) Intravenous dopamine agonist studies in Parkinson’s disease. In: Fahn S, Marsden CD, Jenner P, Teychenne P (eds) Recent developments in Parkinson’s disease. Raven Press, New York, pp 247–253Google Scholar
- Stocchi F, Ruggieri S, Brughitta G, Agnoli A (1986) Problems in daily performances in Parkinson’s disease: the continuous dopaminergic stimulation. J Neural Transm [Suppl] 22: 223–229Google Scholar